Literature DB >> 12183028

The prion protein in human neurodegenerative disorders.

Gabor G Kovacs1, Pietro Zerbi, Till Voigtländer, Michaela Strohschneider, Gianriccardo Trabattoni, Johannes A Hainfellner, Herbert Budka.   

Abstract

We evaluate cellular prion protein (PrP(C)) immunoreactivity (IR) in Alzheimer's, Parkinson's, diffuse Lewy body, and motor neuron diseases (MND), progressive supranuclear palsy, and multiple system atrophy. We use immunohistochemistry for PrP, including five monoclonal antibodies against different epitopes and three different pretreatments, alpha-synuclein, phosphorylated tau, beta-amyloid, and ubiquitin. Disease-specific inclusions are devoid of PrP(C) IR. Using double immunofluorescence and confocal laser microscopy we observe focal overlapping of PrP(C) with tau and with alpha-synuclein in early, but not in fully developed inclusions. However, PrP(C) IR neurons may contain abnormal tau or alpha-synuclein aggregates. Additionally, we observe a loss of PrP(C) IR in anterior horn neurons in MND. Our results suggest that expression of PrP(C) reflects a general response to cellular stress rather than specific co-operation in aggregation of other proteins.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12183028     DOI: 10.1016/s0304-3940(02)00668-7

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  12 in total

1.  Analysis of the polymorphic prion protein gene codon 129 in idiopathic Parkinson's disease.

Authors:  G Gossrau; B Herting; S Möckel; A Kempe; R Koch; H Reichmann; J B Lampe
Journal:  J Neural Transm (Vienna)       Date:  2005-07-06       Impact factor: 3.575

Review 2.  Insoluble cellular prion protein and its association with prion and Alzheimer diseases.

Authors:  Wen-Quan Zou; Xiaochen Zhou; Jue Yuan; Xiangzhu Xiao
Journal:  Prion       Date:  2011-07-01       Impact factor: 3.931

3.  Amyloid-beta42 interacts mainly with insoluble prion protein in the Alzheimer brain.

Authors:  Wen-Quan Zou; Xiangzhu Xiao; Jue Yuan; Gianfranco Puoti; Hisashi Fujioka; Xinglong Wang; Sandy Richardson; Xiaochen Zhou; Roger Zou; Shihao Li; Xiongwei Zhu; Patrick L McGeer; John McGeehan; Geoff Kneale; Diego E Rincon-Limas; Pedro Fernandez-Funez; Hyoung-gon Lee; Mark A Smith; Robert B Petersen; Jian-Ping Guo
Journal:  J Biol Chem       Date:  2011-03-10       Impact factor: 5.157

4.  Prion protein codon 129 polymorphism modifies age at onset of frontotemporal dementia with the C.709-1G>A progranulin mutation.

Authors:  Fermín Moreno; Ainhoa Alzualde; Pablo Martínez Camblor; Myriam Barandiaran; Vivianna M Van Deerlin; Alazne Gabilondo; José F Martí Massó; Adolfo López de Munain; Begoña Indakoetxea
Journal:  Alzheimer Dis Assoc Disord       Date:  2011 Jan-Mar       Impact factor: 2.703

5.  S100A6 amyloid fibril formation is calcium-modulated and enhances superoxide dismutase-1 (SOD1) aggregation.

Authors:  Hugo M Botelho; Sónia S Leal; Isabel Cardoso; Kiran Yanamandra; Ludmilla A Morozova-Roche; Günter Fritz; Cláudio M Gomes
Journal:  J Biol Chem       Date:  2012-10-17       Impact factor: 5.157

6.  Genetic cross-interaction between APOE and PRNP in sporadic Alzheimer's and Creutzfeldt-Jakob diseases.

Authors:  Olga Calero; María J Bullido; Jordi Clarimón; Ana Frank-García; Pablo Martínez-Martín; Alberto Lleó; María Jesús Rey; Alberto Rábano; Rafael Blesa; Teresa Gómez-Isla; Fernando Valdivieso; Jesús de Pedro-Cuesta; Isidro Ferrer; Miguel Calero
Journal:  PLoS One       Date:  2011-07-20       Impact factor: 3.240

7.  Small-molecule induction of Aβ-42 peptide production in human cerebral organoids to model Alzheimer's disease associated phenotypes.

Authors:  Serena Pavoni; Rafika Jarray; Ferid Nassor; Anne-Cécile Guyot; Steve Cottin; Jessica Rontard; Jacqueline Mikol; Aloïse Mabondzo; Jean-Philippe Deslys; Frank Yates
Journal:  PLoS One       Date:  2018-12-17       Impact factor: 3.240

Review 8.  Molecular pathology of human prion diseases.

Authors:  Gabor G Kovacs; Herbert Budka
Journal:  Int J Mol Sci       Date:  2009-03-09       Impact factor: 5.923

Review 9.  Evidence for prion-like mechanisms in several neurodegenerative diseases: potential implications for immunotherapy.

Authors:  Kristen Marciniuk; Ryan Taschuk; Scott Napper
Journal:  Clin Dev Immunol       Date:  2013-10-20

10.  Prion Protein PRNP: A New Player in Innate Immunity? The Aβ Connection.

Authors:  Richard Lathe; Jean-Luc Darlix
Journal:  J Alzheimers Dis Rep       Date:  2017-12-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.